Ming is a Managing Director at Redmile Group, LLC, a healthcare-focused investment firm. Prior to joining Redmile in 2016, Ming worked in the healthcare space as an investor at Safeguard Scientifics, a consultant at McKinsey & Company and ZS Associates, and an operator at Gilead Sciences. Ming graduated with a B.A. in Computer Science from UC Berkeley and an MBA in Finance and Healthcare Management from the Wharton School of Business.
Current role
Director, Strategic Partnerships at Infinity BiologiX
Director Medical Development at Magnosco
Non-Executive Director at INEX Innovate
Associate Director Of Quality And Program Management (head Of QA And Pm) at Cellics Therapeutics
Director at Avastus Preclinical Services